We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
Cap. Flow
+$425M
Cap. Flow %
0.92%
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$128M
2
BKR icon
Baker Hughes
BKR
+$26.7M
3
IQV icon
IQVIA
IQV
+$14.5M
4
OKE icon
Oneok
OKE
+$14.3M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$11.2M

Sector Composition

Rank Sector Weight
1 Financials 16.64%
2 Technology 15.8%
3 Healthcare 13.57%
4 Industrials 10.87%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HASI icon
1801
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.84B
$1.43M ﹤0.01%
58,581
+400
+0.7% +$9.36K
ONTO icon
1802
Onto Innovation
ONTO
$12.9B
$1.43M ﹤0.01%
49,581
+941
+2% +$24.8K
PCTY icon
1803
Paylocity
PCTY
$7.38B
$1.43M ﹤0.01%
29,245
+420
+1% +$19.5K
PRDO icon
1804
Perdoceo Education
PRDO
$1.99B
$1.43M ﹤0.01%
137,253
+3,540
+3% +$32.8K
LPSN icon
1805
LivePerson
LPSN
$21.8M
$1.42M ﹤0.01%
6,997
+154
+2% +$29.6K
PMT
1806
PennyMac Mortgage Investment
PMT
$822M
$1.42M ﹤0.01%
81,769
+858
+1% +$14.9K
WW
1807
DELISTED
WW International
WW
$1.42M ﹤0.01%
32,656
+61
+0.2% +$2.53K
AORT icon
1808
Artivion
AORT
$1.3B
$1.42M ﹤0.01%
62,599
+5,308
+9% +$107K
FPRX
1809
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.42M ﹤0.01%
34,672
+390
+1% +$12.2K
FIVN icon
1810
FIVE9
FIVN
$2.11B
$1.4M ﹤0.01%
58,614
+735
+1% +$15.9K
COTV
1811
DELISTED
Cotiviti Holdings, Inc.
COTV
$1.4M ﹤0.01%
38,840
+8,692
+29% +$327K
UBA
1812
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$1.4M ﹤0.01%
64,371
+257
+0.4% +$5.37K
KOS icon
1813
Kosmos Energy
KOS
$1.6B
$1.39M ﹤0.01%
175,115
+11,717
+7% +$80.9K
FORM icon
1814
FormFactor
FORM
$8.28B
$1.39M ﹤0.01%
82,621
+520
+0.6% +$7.4K
PGTI
1815
DELISTED
PGT, Inc.
PGTI
$1.39M ﹤0.01%
92,817
+2,295
+3% +$30.6K
BNCL
1816
DELISTED
Beneficial Bancorp, Inc.
BNCL
$1.39M ﹤0.01%
83,621
-560
-0.7% -$8.54K
PAHC icon
1817
Phibro Animal Health
PAHC
$1.47B
$1.39M ﹤0.01%
37,405
+1,220
+3% +$45.8K
BJRI icon
1818
BJ's Restaurants
BJRI
$1.42B
$1.38M ﹤0.01%
45,391
+1,240
+3% +$40.2K
FFIC
1819
DELISTED
Flushing Financial
FFIC
$1.38M ﹤0.01%
46,455
-444
-0.9% -$12.4K
NTNX icon
1820
Nutanix
NTNX
$16B
$1.38M ﹤0.01%
61,658
+23,111
+60% +$506K
AMAG
1821
DELISTED
AMAG Pharmaceuticals
AMAG
$1.38M ﹤0.01%
74,765
+1,530
+2% +$28.5K
FNFV
1822
DELISTED
Fidelity Natl Financial, Inc.
FNFV
$1.38M ﹤0.01%
80,235
-1,168
-1% -$19.4K
AFAM
1823
DELISTED
Almost Family Inc
AFAM
$1.38M ﹤0.01%
25,623
+1,155
+5% +$58.9K
FET icon
1824
Forum Energy Technologies
FET
$708M
$1.38M ﹤0.01%
4,325
+30
+0.7% +$8.04K
MBI icon
1825
MBIA
MBI
$261M
$1.37M ﹤0.01%
157,189
+640
+0.4% +$6.42K

Similar funds

RhumbLine Advisers's Q3 2017 Portfolio in Review

As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
  • RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
  • RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
  • RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
  • RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
  • RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.